Statins May Increase Prostate Cancer Risk

One recent study sought to determine whether the use of statin drugs was associated with prostate cancer risk.

The researchers looked at close to 400 prostate cancer patients who had a first-time diagnosis during the period between 2005 and 2008.

They found that use of any statin drug, in any amount, was associated with a significantly increased risk for prostate cancer.

In addition, there was an increasing risk that came along with an increasing cumulative dose.

According to the study:“The results of this case-control study suggest that statins may increase the risk of prostate cancer.”

Statins Have Been Linked to Increased Cancer Risk for More Than a Decade

While the evidence still appears a bit all over the map, with study results ranging from increased cancer risk to reduced risk, to no noticeable risk at all, what IS clear is that conventional medicine still does not understand the full ramifications of artificially lowering your cholesterol levels, and they simply don’t know whether or not the use of these drugs may be adding fuel to an already out of control cancer epidemic.

In short, with well over 30 million Americans now taking statin drugs, we’re witnessing a massive ongoing ‘live’ experiment.

Over 10 years ago, research indicated that besides lowering cholesterol, statins could also promote the growth of new blood vessels. And, although this effect may help to prevent heart attacks and other forms of heart disease, it may also promote cancer as well by increasing the growth of blood vessels in cancerous tumors. Meanwhile, other studies have indicated the complete opposite; that statins can inhibit angiogenesis (the formation of new blood vessels), so again, it’s virtually impossible to say that statin safety and effectiveness is based on hard science…

But the statin-cancer connection actually goes much farther back than that. A review published in the Journal of the American Medical Association in 1996 stated:“All members of the two most popular classes of lipid-lowering drugs (the fibrates and the statins) cause cancer in rodents, in some cases at levels of animal exposure close to those prescribed to humans. …

Longer-term clinical trials and careful postmarketing surveillance during the next several decades are needed to determine whether cholesterol-lowering drugs cause cancer in humans.

In the meantime, the results of experiments in animals and humans suggest that lipid-lowering drug treatment, especially with the fibrates and statins, should be avoided except in patients at high short-term risk of coronary heart disease.”

Cholesterol Guidelines are a Health Disaster

Needless to say, such warnings were completely ignored. Instead, public health officials have gone the opposite way, happily following the trail littered with the most cash.

Over the past decade, cholesterol guidelines have been altered to create ever more ‘patients’ to be treated with cholesterol-lowering drugs. In 2004, the U.S. government’s National Cholesterol Education Program panel advised those at risk for heart disease to attempt to reduce their LDL (bad) cholesterol to extremely low levels, and it’s been a health disaster ever since.

FDA Doesn’t “Believe” in Statin-Cancer Link

Back in 2008, troubling study findings were released showing a dramatically increased risk of cancer related deaths in those taking Inegy (also sold under the trade name Vytorin). The drug combines the widely-used statin drug simvastatin with another medication called ezetimibe, which blocks the absorption of cholesterol in your gut. The study also found no benefit whatsoever from the drug.

This despite the fact that it reduced LDL cholesterol levels by a respectable 61 percent, which “should have” had an effect on cardiovascular events, based on the prevailing hypothesis that high LDL equates to high risk of heart disease. So, in a nutshell, the drug had no beneficial impact on the primary outcome (meaning it did not reduce major cardiovascular adverse events), while more people developed cancer on the treatment (105 versus 70 patients taking a placebo), and more cancer related deaths (39 cancer deaths versus 23 in the control group).

A couple of months after the results were revealed, a panel assembled by the American Academy of Cardiology declared that:“… the aggressively marketed drug combination should be used only as a last resort. There is currently no evidence that ezetimibe, which reduces levels of low-density lipoprotein cholesterol, improves clinical outcomes such as myocardial infarction or death.”

Their conclusion?“FDA believes it is unlikely that Vytorin or Zetia increase the risk of cancer or cancer-related death.”

I don’t know how much faith you have in the FDA’s beliefs, but mine is on pretty shaky ground… The FDA goes on to list a number of factors that were weighed to reach the conclusion that they believe cancer is unrelated to the drugs. You can review them for yourself here, and see if you would concur with their assessment.

Statins May Increase Your Risk of Heart Disease

Ironically, while reducing your risk of cardiovascular events and heart disease is the primary motivation for prescribing statins, these drugs can actually increase your risk of heart disease because they deplete your body of Coenzyme Q10 (CoQ10), which can lead to heart failure. Statins have also been linked to:

Weakness

Serious degenerative muscle tissue condition (rhabdomyolysis)

Pancreas or liver dysfunction, including a potential increase in liver enzymes

The Importance of CoQ10 or, if You’re Over 40, Ubiquinol

As mentioned in the beginning, statin drugs also block the production of Coenzyme Q10 (CoQ10), and that in and of itself poses a very serious health risk. As your body gets more and more depleted of CoQ10, you may suffer from fatigue, muscle weakness and soreness, and eventually heart failure. Coenzyme Q10 plays a vital role in the process of neutralizing free radicals and the optimal production of cellular energy.

Unfortunately, the majority of people who take statins are unaware of their need for CoQ10, and physicians rarely advise their patients to take this supplement along with their statin—at least in the United States. It’s also important to supplement right from the start, to ward off irreversible mitochondrial damage.

Unlike prescription drugs that kill over 125,000 people every year in the U.S. alone, there are no reported side effects of CoQ10 supplementation and no one has ever died from taking it.

What Drug Companies Don’t Want You to Know About LDL

While statins drugs are very effective for lowering so-called “bad” cholesterol, the low-density lipoprotein, or LDL, it’s important to realize that there are different sizes of LDLcholesterol particles, and it’s the LDL particle size that is relevant,as small particles get stuck easily and causes more inflammation. Unfortunately, most people don’t hear about that part, and very rarely, if ever, get it tested.

Naturally, the drug companies really don’t want you to know about this, because statins do not modulate the size of the particles.

The only way to make sure your LDL particles are large enough to not get stuck and cause inflammation and damage is through your diet. In fact, modulating LDL particle size is one of the things that insulin does. If you eat properly and maintain normal insulin levels, then everything works as it should—the LDL particles are large and buoyant; they don’t get stuck, and don’t cause inflammation.

So rather than worry about your cholesterol numbers, you really want to work on reducing inflammation, which can be caused by numerous things, including:

Oxidized cholesterol (cholesterol that has gone rancid, such as that from overcooked, scrambled eggs)

Eating lots of sugar and grains

Eating foods cooked at high temperatures

Eating trans fats

A sedentary lifestyle

Smoking

Emotional stress

When you get to the bottom of it, the real “villain” of heart disease is typically an unhealthy lifestyle, characterized by a heavy reliance on sugars and grains, processed, highly cooked foods, and insufficient amounts of exercise – not “high cholesterol” per se.

We Lost the War on Cancer – Review of Alternative Cancer Therapies

We have lost the war on cancer. At the beginning of the last century, one person in twenty would get cancer. In the 1940s it was one out of every sixteen people. In the 1970s it was one person out of ten. Today one person out of three gets cancer in the course of their life.

The cancer industry is probably the most prosperous business in the United States. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, such as the National Cancer Institute (NCI). The NCI states that the medical costs of cancer care are $125 billion, with a projected 39 percent increase to $173 billion by 2020.

The simple fact is that the cancer industry employs too many people and produces too much income to allow a cure to be found. All of the current research on cancer drugs is based on the premise that the cancer market will grow, not shrink.

John Thomas explains to us why the current cancer industry prospers while treating cancer, but cannot afford to cure it in Part I. In Part II, he surveys the various alternative cancer therapies that have been proven effective, but that are not approved by the FDA.

Read We Lost the War on Cancer – Review of Alternative Cancer Therapies on your mobile device!